Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaspal Phull

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|September 20, 2012
Time to think about a universal system, again?Michelle Carey, Jaspal Phull
Cureus|July 14, 2025
Rare Breast Metastasis From Urothelial Carcinoma: A Case Report and Literature ReviewTarek Mohamed, Hamza Elhashamy, Mohamed Ramez, et al.
European Urology|August 23, 2022
Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled TrialWei Shen Tan, Aaron Prendergast, Charlotte Ackerman, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|September 20, 2012
Time to think about a universal system, again?Michelle Carey, Jaspal Phull
Cureus|July 14, 2025
Rare Breast Metastasis From Urothelial Carcinoma: A Case Report and Literature ReviewTarek Mohamed, Hamza Elhashamy, Mohamed Ramez, et al.
European Urology|August 23, 2022
Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled TrialWei Shen Tan, Aaron Prendergast, Charlotte Ackerman, et al.
Pageof 1